EYE 2.86% 18.0¢ nova eye medical limited

EYE Summary (August 2024): Incredibly Undervalued, page-122

  1. 16,311 Posts.
    lightbulb Created with Sketch. 4359
    I agree @Stonks, fair value of $2 is probably too conservative of an estimate. However, the view of myself and my institutional colleague is that conservative is always better than aggressive when it comes to valuation. Whilst the company will clearly perform will in excess of our forecasts, by taking a conservative approach we ensure that the risk of any unforeseen events are accounted for in the price target. As such, we have chosen a fair value price of $2 as opposed to one closer to $10 (which is closer to peer valuations during their own growth stages). Call me a bear or a downramper for suggesting such a low price target, but I feel this is the safe way to play it! Do you agree?
    Last edited by TheAnalyst007: 18/08/24
 
watchlist Created with Sketch. Add EYE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.